Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Silver

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Clinical and Translational Science|April 2, 2009
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetesAllison B Goldfine, Robert Silver, Waleed Aldhahi, et al.
Molecular and Cellular Biology|November 16, 2004
A mammalian ortholog of Saccharomyces cerevisiae Vac14 that associates with and up-regulates PIKfyve phosphoinositide 5-kinase activityDiego Sbrissa, Ognian C Ikonomov, Jana Strakova, et al.
The New England Journal of Medicine|September 22, 2020
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin TreatmentJulio Rosenstock, Harpreet S Bajaj, Andrej Janež, et al.
The Journal of Mental Health Policy and Economics|January 21, 2026
Cost-Effectiveness of Transcranial Magnetic Stimulation for Methamphetamine Use Disorder during PregnancyRana Jawish, Abdelrahman G Tawfik, Brian Mickey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 14, 2019
GREATER COMBINED REDUCTIONS IN HbA<sub>1C</sub> ≥1.0% AND WEIGHT ≥5.0% WITH SEMAGLUTIDE VERSUS COMPARATORS IN TYPE 2 DIABETESHelena W Rodbard, Srikanth Bellary, Irene Hramiak, et al.
AJP Reports|June 15, 2016
Fetoscopic Amniotic Band Release in a Case of Chorioamniotic Separation: An Innovative New TechniqueMichael A Belfort, William E Whitehead, Robert Ball, et al.
Diabetes, Obesity & Metabolism|June 20, 2019
Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trialsJohan Jendle, Andreas L Birkenfeld, William H Polonsky, et al.
O&G Open|September 26, 2025
Social Determinants of Health and Disparities in Pregnancy OutcomesKazuma Onishi, Alfred Abuhamad, George Saade, et al.
The Lancet. Diabetes & Endocrinology|June 14, 2019
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trialVanita R Aroda, Guillermo González-Galvez, Randi Grøn, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2016
Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live BirthTorie C Plowden, Enrique F Schisterman, Lindsey A Sjaarda, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Clinical and Translational Science|April 2, 2009
Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetesAllison B Goldfine, Robert Silver, Waleed Aldhahi, et al.
Molecular and Cellular Biology|November 16, 2004
A mammalian ortholog of Saccharomyces cerevisiae Vac14 that associates with and up-regulates PIKfyve phosphoinositide 5-kinase activityDiego Sbrissa, Ognian C Ikonomov, Jana Strakova, et al.
The New England Journal of Medicine|September 22, 2020
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin TreatmentJulio Rosenstock, Harpreet S Bajaj, Andrej Janež, et al.
The Journal of Mental Health Policy and Economics|January 21, 2026
Cost-Effectiveness of Transcranial Magnetic Stimulation for Methamphetamine Use Disorder during PregnancyRana Jawish, Abdelrahman G Tawfik, Brian Mickey, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 14, 2019
GREATER COMBINED REDUCTIONS IN HbA<sub>1C</sub> ≥1.0% AND WEIGHT ≥5.0% WITH SEMAGLUTIDE VERSUS COMPARATORS IN TYPE 2 DIABETESHelena W Rodbard, Srikanth Bellary, Irene Hramiak, et al.
AJP Reports|June 15, 2016
Fetoscopic Amniotic Band Release in a Case of Chorioamniotic Separation: An Innovative New TechniqueMichael A Belfort, William E Whitehead, Robert Ball, et al.
Diabetes, Obesity & Metabolism|June 20, 2019
Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trialsJohan Jendle, Andreas L Birkenfeld, William H Polonsky, et al.
O&G Open|September 26, 2025
Social Determinants of Health and Disparities in Pregnancy OutcomesKazuma Onishi, Alfred Abuhamad, George Saade, et al.
The Lancet. Diabetes & Endocrinology|June 14, 2019
Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trialVanita R Aroda, Guillermo González-Galvez, Randi Grøn, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2016
Subclinical Hypothyroidism and Thyroid Autoimmunity Are Not Associated With Fecundity, Pregnancy Loss, or Live BirthTorie C Plowden, Enrique F Schisterman, Lindsey A Sjaarda, et al.
Pageof 5